HL7 Terminology (THO)
3.1.0 - Publication International flag

This page is part of the HL7 Terminology (v3.1.0: Release) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

CodeSystem: Substance Admin Substitution

Official URL: http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution Version: 2.1.0
Active as of 2019-03-20 Responsible: Health Level 7 Computable Name: SubstanceAdminSubstitution
Other Identifiers: : urn:oid:2.16.840.1.113883.5.1070

Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.

This Code system is referenced in the content logical definition of the following value sets:

Properties

CodeURLTypeDescription
SpecializesCodingThe child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.
GeneralizesCodingInverse of Specializes. Only included as a derived relationship.
internalIdhttp://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-idcodeThe internal identifier for the concept in the HL7 Access database repository.
notSelectablehttp://hl7.org/fhir/concept-properties#notSelectablebooleanIndicates that the code is abstract - only intended to be used as a selector for other concepts
statushttp://hl7.org/fhir/concept-properties#statuscodeDesignation of a concept's state. Normally is not populated unless the state is retired.

This code system http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution defines the following codes:

LvlCodeDisplayDefinitioninternalIdNot Selectablestatus
1_ActSubstanceAdminSubstitutionCode ActSubstanceAdminSubstitutionCode**Description:** Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.21284trueactive
2  E equivalent**Description:** Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.23107active
3    EC equivalent composition**Description:** Substitution occurred or is permitted with another product that is a: * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration *Examples:* * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate * *Pharmaceutical equivalent:* Lisonpril for Zestril23108active
4      BC brand composition**Description:** Substitution occurred or is permitted between equivalent Brands but not Generics *Examples:* * Zestril for Prinivil * Coumadin for Jantoven23109active
4      G generic composition**Description:** Substitution occurred or is permitted between equivalent Generics but not Brands *Examples:* * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)16623active
3    TE therapeutic alternative**Description:** Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. *Examples:* * ranitidine for Tagamet16624active
4      TB therapeutic brand**Description:** Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > *Examples:* * Zantac for Tagamet23105active
4      TG therapeutic generic**Description:** Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > *Examples:* * Ranitidine for cimetidine23106active
2  F formulary**Description:** This substitution was performed or is permitted based on formulary guidelines.16625active
2  N noneNo substitution occurred or is permitted.16622active

History

DateActionCustodianAuthorComment
2022-02-17 12:00:32+1100reviseVocabulary WGGrahame GrievePopulate Missing caseSensitive property; UP-286
2020-05-06reviseVocabulary WGTed KleinMigrated to the UTG maintenance environment and publishing tooling.